Difamilast

Overview

Difamilast (OPA-15406) is a topical, selective and nonsteroidal phosphodiesterase-4 ( PDE4 ) inhibitor with particularly efficient inhibition of subtype B ( IC 50 =11.2 nM). Difamilast can be used for the research of mild to moderate atopic dermatitis (AD).

Application

Products | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Depression | Products > Disease Areas > Alzheimer's Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Colorectal Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Phosphodiesterase (PDE)

Product Information

• Catalog No.: HY-109085
• CAS No.: 937782-05-3
• Molecular Formula: C23H24F2N2O5
• Molecular Weight: 446.44
• Purity: 99.38%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: 2.5 mg/mL (5.60 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source